2018 ESMO临床实践指南：原发性皮肤淋巴瘤的诊断、治疗与随访.pdfVIP

Annals of Oncology 29 (Supplement 4): iv30–iv40, 2018 doi:10.1093/annonc/mdy133 CLINICAL PRACTICE GUIDELINES Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† 1 2 3 4 5 * R. Willemze , E. Hodak , P. L. Zinzani , L. Specht M. Ladetto , on behalf of the ESMO Guidelines Committee 1Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; 2Department of Dermatology, Rabin Medical Centre, Beilinson Hospital, Petach Tikva, Israel; 3Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy; 4 Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 5Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy *Correspondence to: ESMO Guidelines Committee, ESMO Head Office, Via Ginevra 4, 6900 Lugano, Switzerland. E-mail: clinicalguidelines@ †Approved by the ESMO Guidelines Committee: December 2006, last update January 2018. This publication supersedes the previously published version—Ann Oncol 2013; 24 (Suppl. 6): vi149–vi154. Incidence and epidemiology immunoglobulin gene rearrangements in lesional skin or peripheral blood may be a valuable adjunct in selected cases. However, clinical Primary cutaneous lymphomas (PCLs) are defined as non- and histopathological features are, in most cases, the most import- Hod